InformAI
Houston, US · Founded 2017 · 10 employees on LinkedIn · 3 known investors
InformAI develops AI-guided clinical solutions for oncology and diagnostic imaging to improve patient treatment outcomes. The company specializes in radiation oncology dose prediction, with their RadOncAI platform designed to optimize head and neck radiation therapy planning while reducing exposure to healthy tissues.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeed PlusMar 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does InformAI do?
- InformAI develops AI-guided clinical solutions for oncology and diagnostic imaging to improve patient treatment outcomes. The company specializes in radiation oncology dose prediction, with their RadOncAI platform designed to optimize head and neck radiation therapy planning while reducing exposure to healthy tissues.
- Who are InformAI's investors?
- InformAI's investors include Joyance Partners, Social Starts, DEFTA Partners.
- Where is InformAI headquartered?
- InformAI is headquartered in Houston, US.